Aerie Pharmaceuticals Depreciation & Amortization 2011-2026 | AERI

Annual Depreciation & Amortization Aerie Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.4 M	6.37 M	5.14 M	2.44 M	1.41 M	970 K	252 K	73 K	64 K	138 K	120 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.4 M	64 K	2.12 M

Quarterly Depreciation & Amortization Aerie Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	1.6 M	-	-	-	1.5 M	-	4.74 M	3.19 M	1.59 M	-	3.61 M	2.06 M	564 K	-	1.73 M	1.08 M	487 K	-	916 K	600 K	291 K	-	702 K	457 K	223 K	-	102 K	60 K	24 K	-	50 K	31 K	15 K	-	47 K	30 K	15 K	-	104 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.74 M	15 K	956 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.04	-3.7 %	$ 112 M	Canada
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Evolus EOLS	7.51 M	$ 5.8	3.76 %	$ 374 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.6	3.05 %	$ 10.5 M	China
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.56	-3.0 %	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Harrow Health HROW	1.32 M	$ 36.69	-6.45 %	$ 1.35 B	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Organogenesis Holdings ORGO	13.6 M	$ 2.88	0.17 %	$ 379 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Emergent BioSolutions EBS	125 M	$ 8.45	-3.65 %	$ 433 M	USA
Assertio Holdings ASRT	28.2 M	$ 11.87	-1.66 %	$ 843 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.59	-0.71 %	$ 2.04 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Veru VERU	268 K	$ 2.54	1.2 %	$ 343 M	USA
Perrigo Company plc PRGO	338 M	$ 11.26	-3.68 %	$ 1.56 B	USA
TherapeuticsMD TXMD	922 K	$ 2.23	3.06 %	$ 23.3 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Viatris VTRS	2.74 B	$ 14.53	-1.26 %	$ 17.4 B	USA
Rockwell Medical RMTI	1.44 M	$ 0.88	-1.31 %	$ 20.5 M	USA
Pacira BioSciences PCRX	78.8 M	$ 22.91	0.22 %	$ 1.06 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
cbdMD YCBD	452 K	$ 0.73	-5.6 %	$ 3.15 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.43	-7.02 %	$ 133 M	USA
SCYNEXIS SCYX	580 K	$ 0.78	1.1 %	$ 38.9 M	USA
Solid Biosciences SLDB	2.46 M	$ 5.61	-8.71 %	$ 229 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.45	-12.5 %	$ 3.04 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Tilray TLRY	35.7 M	$ 7.06	-3.36 %	$ 4.36 B	Canada
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA